CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.21, no.7, pp.678-683, 2015 (SCI-Expanded)
Background: There have been concerns about the possible prothrombotic effects of nilotinib, especially in patients having cardiovascular risk factors. The potential mechanism behind the increased risk of thromboembolic events is still not clear.